| 生物活性 | |||
|---|---|---|---|
| 描述 | Omecamtiv mecarbil at 10 μM reduces the maximum rate of ATP hydrolysis (kcat) by 4.5-fold and lowers the actin concentration needed for half-maximal ATPase activity (KATPase) by 30-fold. The EC50 of Omecamtiv mecarbil-induced inhibition of actin-activated ATPase is determined to be 0.52 ± 0.10 μM. It does not alter overall actin affinity but causes a state of weak actin affinity in a subset of myosin heads with slow product release. In an in vitro motility assay, it reduces the actin sliding velocity by more than 100-fold[3]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.49mL 0.50mL 0.25mL | 12.46mL 2.49mL 1.25mL | 24.91mL 4.98mL 2.49mL | 
| 参考文献 | 
|---|